Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leonid S Metelitsa

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Clinical Immunology (Orlando, Fla.)|November 25, 2010
Anti-tumor potential of type-I NKT cells against CD1d-positive and CD1d-negative tumors in humansLeonid S Metelitsa
Clinical Immunology (Orlando, Fla.)|March 30, 2004
Flow cytometry for natural killer T cells: multi-parameter methods for multifunctional cellsLeonid S Metelitsa
European Journal of Immunology|November 21, 2002
NKT and T cells: coordinate regulation of NK-like phenotype and cytokine productionMatthew J Loza, Leonid S Metelitsa, Bice Perussia
Blood|November 8, 2022
Natural killer T cells and other innate-like T lymphocytes as emerging platforms for allogeneic cancer cell therapyAmy N Courtney, Gengwen Tian, Leonid S Metelitsa
Chembiochem : a European Journal of Chemical Biology|September 30, 2006
Synthesis and evaluation of an alpha-C-galactosylceramide analogue that induces Th1-biased responses in human natural killer T cellsXuequan Lu, Liping Song, Leonid S Metelitsa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 21, 2025
Facts and Hopes of Chimeric Antigen Receptor-Redirected NK T CellsAmy N Courtney, Xin Zhou, Gengwen Tian, et al.
Blood|May 16, 2002
Antidisialoganglioside/granulocyte macrophage-colony-stimulating factor fusion protein facilitates neutrophil antibody-dependent cellular cytotoxicity and depends on FcgammaRII (CD32) and Mac-1 (CD11b/CD18) for enhanced effector cell adhesion and azurophil granule exocytosisLeonid S Metelitsa, Stephen D Gillies, Michael Super, et al.
Cancer Research|April 25, 2015
G-CSF Promotes Neuroblastoma Tumorigenicity and Metastasis via STAT3-Dependent Cancer Stem Cell ActivationSaurabh Agarwal, Anna Lakoma, Zaowen Chen, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 15, 2011
Selective gene transfection of individual cells in vitro with plasmonic nanobubblesEkaterina Y Lukianova-Hleb, Adam P Samaniego, Jianguo Wen, et al.
Cancer Immunology Research|January 18, 2019
NK Cells Expressing a Chimeric Activating Receptor Eliminate MDSCs and Rescue Impaired CAR-T Cell Activity against Solid TumorsRobin Parihar, Charlotte Rivas, Mai Huynh, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Clinical Immunology (Orlando, Fla.)|November 25, 2010
Anti-tumor potential of type-I NKT cells against CD1d-positive and CD1d-negative tumors in humansLeonid S Metelitsa
Clinical Immunology (Orlando, Fla.)|March 30, 2004
Flow cytometry for natural killer T cells: multi-parameter methods for multifunctional cellsLeonid S Metelitsa
European Journal of Immunology|November 21, 2002
NKT and T cells: coordinate regulation of NK-like phenotype and cytokine productionMatthew J Loza, Leonid S Metelitsa, Bice Perussia
Blood|November 8, 2022
Natural killer T cells and other innate-like T lymphocytes as emerging platforms for allogeneic cancer cell therapyAmy N Courtney, Gengwen Tian, Leonid S Metelitsa
Chembiochem : a European Journal of Chemical Biology|September 30, 2006
Synthesis and evaluation of an alpha-C-galactosylceramide analogue that induces Th1-biased responses in human natural killer T cellsXuequan Lu, Liping Song, Leonid S Metelitsa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 21, 2025
Facts and Hopes of Chimeric Antigen Receptor-Redirected NK T CellsAmy N Courtney, Xin Zhou, Gengwen Tian, et al.
Blood|May 16, 2002
Antidisialoganglioside/granulocyte macrophage-colony-stimulating factor fusion protein facilitates neutrophil antibody-dependent cellular cytotoxicity and depends on FcgammaRII (CD32) and Mac-1 (CD11b/CD18) for enhanced effector cell adhesion and azurophil granule exocytosisLeonid S Metelitsa, Stephen D Gillies, Michael Super, et al.
Cancer Research|April 25, 2015
G-CSF Promotes Neuroblastoma Tumorigenicity and Metastasis via STAT3-Dependent Cancer Stem Cell ActivationSaurabh Agarwal, Anna Lakoma, Zaowen Chen, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 15, 2011
Selective gene transfection of individual cells in vitro with plasmonic nanobubblesEkaterina Y Lukianova-Hleb, Adam P Samaniego, Jianguo Wen, et al.
Cancer Immunology Research|January 18, 2019
NK Cells Expressing a Chimeric Activating Receptor Eliminate MDSCs and Rescue Impaired CAR-T Cell Activity against Solid TumorsRobin Parihar, Charlotte Rivas, Mai Huynh, et al.
Pageof 5